Regulation of bcl-2 and fas expression in primary activation of human peripheral lymphocytes is not sensitive to dexamethasone or cyclosporin-A

Human Immunology

Volumn 50, Issue 2, 1996, Pages 121-126

  Sfikakis, Peter P ^a,d   Souliotis, Vassillis L ^b   Akbar, Arnie N ^c   Katsilambros, Nikos ^a   Hoffbrand, Victor A ^c   Panayiotidis, Panayiotis ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; FAS ANTIGEN; PROTEIN BCL 2;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030272439     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(96)00136-X     Document Type: Article

References (39)

1. 1. Hawkins CJ, Vaux DL: Analysis of the role of bcl-2 in apoptosis. Immunol Rev 142:127, 1994.
2. 2. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW: Enforced BCL-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8661, 1991.
3. 3. Strasser A, Harris AW, Cory S: BCL-2 transgene inhibits T cell death and perturbs thymic self-sensorchip. Cell 67:889, 1991.
4. 4. Nagata S, Golstein P: The fas death factor. Science 267: 1449, 1995.
5. 5. Alderson MR, Armitage RJ, Marakovsky E, Tough TW, Roux E, Schooley K, Ramsdell F, Lynch DH: Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231, 1993.
6. 6. Nakayama K-I, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louis MC, Fields LE, Lucas PJ, Stewart V, Alt FW, Loh DY: Disappearance of the lymphoid system in bcl-2 homozygous mutant himeric mice. Science 261: 1584, 1993.
7. 7. Nagata S, Suda T. Fas and Fas-ligand: lpr and gld mutations. Immunol Today 16:39, 1995.
8. 8. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with hyman lymphoproliferarive syndrome and autoimmunity. Science 268:1347, 1995.
9. 9. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935, 1995.
10. 10. Yoshino T: Inverse expression of bcl-2 protein and fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83:1856, 1994.
11. 11. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on fas antigen-mediated cell death. J Immunol 151:621, 1993.
12. 12. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity. Cell 80:279, 1995.
13. 13. Taniguchi T, Minami Y: The IL-2/IL-2 receptor system: a current overview. Cell 73:5, 1993.
14. 1) lymphocytes. II. Glucocorticoid and antiTac-induced inhibition of human T lymphocyte proliferation. J Immunol 132:261, 1984.
15. 15. Reed SC, Abide AH, Alpers JD, Hoover RG, Robb RJ, Nowell PC: Effect of cyclosporin and dexamethasone on interleukin-2 receptor gene expression. J Immunol 137: 150, 1986.
16. 16. Sfikakis PP, Souliotis V, Panayotides PP. Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells. Arthritis Rheum 36:208, 1993.
17. 17. Hernandez-Caselles T, Martinez-Esparza M, Sancho D, Rubio G, Aparicio P: Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expression. Hum Immunol 43:181, 1995.
18. 18. Tuosto L, Cundari E, Montani MSG, Piccolella E. Analysis of susceptibility of mature human lymphocytes to dexamethasone-induced apoptosis. Eur J Immunol 24: 1061, 1994.
19. 19. Wyllie AH: Glycocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555, 1980.
20. 20. Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH: Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol 144:251, 1990.
21. cdc2 kinase activation in T lymphocytes. J Biol Chem 268:22737, 1993.
22. 22. Shi Y, Szalay MG, Paskar L, Boyer M, Singh B, Green DR: Activation-induced cell death in T-cell hybridomas is due to apoptosis. J Immunol 144:3326, 1990.
23. 23. Shi Y, Sahai M, Green DR: Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339:625, 1989.
24. 24. Kroemer G, Martinez AC: Pharmacological inhibition of programmed lymphocyre death. Immunol Today 15:235, 1994.
25. 25. Gottschalk AR, Boise LH, Thompson CB, Quintans J: Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc Natl Acad Sci USA 91:7350, 1994.
26. 26. Vanier LE, Prud'homme GJ. Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction. J Exp Med 176:37, 1992.
27. 27. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV. Expression and function of the fas antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia 9:1227, 1995.
28. 28. Itoh N, Yonehara S, Ishii A, Yonehara m, Mizushima SI, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for the human cell surface antigen fas can mediate apoptosis. Cell 66:233, 1991.
29. 29. Berger SL: Isolation of cytoplasmic RNA: ribonucleotide-vanadyl complexes. Methods Enzymol 152:227, 1987.
30. 30. Thomas PS: Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201, 1980.
31. 31. Lehrach HD, Diamond D, Wozney JM, Boedtker H: RNA molecular weight determinations by gel electrophoresis under denaturing conditions: a critical reexamination. Biochemistry 16:4743, 1977.
32. 32. Panayiotidis P, Kanagasabai G, Jabbar SAB, Hoffbrand AV: Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukemia cells in vitro. Br J Haematol 85:439, 1993.
33. 33. Stewart CC, Ctamer SF, Steward PG: The response of human peripheral blood lymphocytes to phytohemagglutinin: determination of cell numbers. Cell Immunol 16: 237, 1975.
34. 34. Reed JC, Tsujimoto Y, Alpers JD, Croce CM, Nowell P: Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 236: 1295, 1987.
35. 35. Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753, 1992.
36. 36. Deng G, Podack ER: Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 90:2189, 1993.
37. 37. Gonzalo JA, Bonzalex-Garcia A, Martinez AC, Kroemer G: Glycocorticoid-mediated control of activation and clonal deletion of peripheral T cell in vivo. J Exp Med 177:1239, 1993.
38. 38. Vacchio M, Papadopoulos V, Ashwell JD: Steroid production in the thymus: implications for thymocyte selection. J Exp Med 179:1835, 1994.
39. 39. Theofilopoulos AN: The basis of autoimmunity: part II. Genetic predisposition. Immunol Today 16:150, 1995.